Showing results (451-460 of 1,340) with videos related to
Sort By:
Pageof 134
Neuro-Oncology Advances|August 1, 2025
Bevacizumab alternating chemotherapy for improving the survival of patients with recurrent high-grade gliomaPing-Chuan Liu, Chao-Yang Kuo, Yi-Wei Chen, et al.Neuro-Oncology Advances|July 25, 2025
Patterns of relapse in diffuse intrinsic pontine glioma after convection-enhanced delivery of 124I-omburtamabEvan D Bander, Andrew L A Garton, Luca Pasquini, et al.Neuro-Oncology Advances|July 25, 2025
Selumetinib in pediatric patients with neurofibromatosis type 1 and plexiform neurofibroma: Propensity score analysis of SPRINT vs. natural history control armAyo Adeyemi, Andrea M Gross, Andrea Baldwin, et al.Neuro-Oncology Advances|July 28, 2025
Interpretable artificial intelligence based determination of glioma IDH mutation status directly from histology slidesShubham Innani, W Robert Bell, Hannah Harmsen, et al.Neuro-Oncology Advances|July 28, 2025
Seizure characteristics and outcomes in patients with pleomorphic xanthoastrocytomaDaniel J Zhou, Colin A Ellis, Kevin Xie, et al.Neuro-Oncology Advances|July 28, 2025
Deep learning volumetrics reveal distinct clinical trajectories for pediatric low-grade gliomas under surveillance: A multicenter studyJuan Carlos Climent Pardo, Anna Zapaishchykova, Aidan Boyd, et al.Neuro-Oncology Advances|July 28, 2025
Nuances in visual rehabilitation after pituitary surgerySaksham Gupta, Wenya Linda BiNeuro-Oncology Advances|March 26, 2025
Emerging mechanism and therapeutic potential of neurofibromatosis type 1-related nerve system tumor: Advancing insights into tumor developmentXuan Yu, Yihui Gu, Jun Liu, et al.Neuro-Oncology Advances|November 25, 2020
Combination MEK and mTOR inhibitor therapy is active in models of glioblastomaKarisa C Schreck, Amy N Allen, Jiawan Wang, et al.Neuro-Oncology Advances|November 26, 2020
RNAi technology targeting the FGFR3-TACC3 fusion breakpoint: an opportunity for precision medicineBrittany C Parker Kerrigan, Daniel Ledbetter, Matthew Kronowitz, et al.Pageof 134